Clinical trial approval / initiation

Explore the landscape of Clinical trial approval / initiation in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Clinical trial approval / initiation to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Xinhua Pharmaceutical Secures NMPA Registration for Generic Sacubitril/Valsartan Tablets – Entering China's RMB 7.8 Billion Heart Failure Market
CompanyDrug

Xinhua Pharmaceutical Secures NMPA Registration for Generic Sacubitril/Valsartan Tablets – Entering China’s RMB 7.8 Billion Heart Failure Market

Shandong Xinhua Pharmaceutical Company Limited (HKG: 0719, SHE: 000756) announced that it has received a Drug Registration Certificate from China's National Medical Products Administration (NMPA) for Sacubitril/Valsartan Sodium Tablets (sacubitril…

SSY Group Secures NMPA Approval for Nimodipine Oral Solution – Bulk Drug‑to‑Formulation Vertical Integration Strengthens Cerebrovascular Portfolio

Novartis' Rhapsido (Remibrutinib) Wins FDA Approval – First‑in‑Class BTK Inhibitor Becomes First Approved Treatment for Symptomatic Dermographism

Novartis’ Rhapsido (Remibrutinib) Wins FDA Approval – First‑in‑Class BTK Inhibitor Becomes First Approved Treatment for Symptomatic Dermographism

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Isap Biotech Secures FDA IND Approval for iSAP-0909 for Bladder Cancer Imaging
CompanyDrug

Isap Biotech Secures FDA IND Approval for iSAP-0909 for Bladder Cancer Imaging

Jiuzhitang Co., Ltd Announces Clinical Clearance for Volagidemab in Type 1 Diabetes
CompanyDrug

Jiuzhitang Co., Ltd Announces Clinical Clearance for Volagidemab in Type 1 Diabetes

Shenzhen Chipscreen Biosciences Receives NMPA Approval for Chiauranib Clinical Study
CompanyDrug

Shenzhen Chipscreen Biosciences Receives NMPA Approval for Chiauranib Clinical Study

Novartis' Trispecific Antibody PIT565 Secures NMPA Approval for Clinical Trial
CompanyDrug

Novartis’ Trispecific Antibody PIT565 Secures NMPA Approval for Clinical Trial

Chipscreen Biosciences' Tivozanib Secures NMPA Approval for ES-SCLC Phase III Trial
CompanyDrug

Shenzhen Chipscreen Biosciences’ Tivozanib Secures NMPA Approval for ES-SCLC Phase III Trial

Tasly Pharmaceuticals Gets FDA Approval for Acute Ischemic Stroke Cell Therapy Clinical Study
CompanyDrug

Tasly Pharmaceuticals Gets FDA Approval for Acute Ischemic Stroke Cell Therapy Clinical Study

Zhejiang Huahai Pharmaceutical Gets New Zealand Approval for Asthma Bispecific Antibody Trial
CompanyDrug

Zhejiang Huahai Pharmaceutical Gets New Zealand Approval for Asthma Bispecific Antibody Trial

Youcare Pharmaceutical Group Gets NMPA Approval for YKYY015 Phase I Study
CompanyDrug

Youcare Pharmaceutical Group Gets NMPA Approval for YKYY015 Phase I Study

Show More